TC
CALA

TFS Capital’s Calithera Biosciences, Inc CALA Stock Holding History

TFS Capital’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-858
Closed -$255K – 436
2017
Q2 		$255K Buy
+858
New +$229K 0.1% 385
2017
Q1 		– Sell
-1,420
Closed -$92K – 918
2016
Q4 		$92K Buy
+1,420
New +$88.7K 0.02% 651
2016
Q2 		– Sell
-2,430
Closed -$276K – 1243
2016
Q1 		$276K Buy
+2,430
New +$275K 0.04% 678
2015
Q3 		– Sell
-857
Closed -$122K – 1096
2015
Q2 		$122K Buy
+857
New +$199K 0.01% 798

Other funds holding CALA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AC
Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

TFS Capital's CALA Position: Q3 2017 in Review

TFS Capital sold out of Calithera Biosciences, Inc (CALA) in Q3 2017, closing a stake of 858 shares — an estimated $255K sold.

TFS Capital first reported a position in CALA in Q2 2015 and held it in 4 quarters. The position peaked at $276K in Q1 2016. 91 funds tracked by Wall St. Rank hold CALA as of Q3 2017.

  • TFS Capital reported no remaining Calithera Biosciences, Inc position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 858 Calithera Biosciences, Inc shares in Q3 2017, an estimated $255K.
  • TFS Capital first reported a position in Calithera Biosciences, Inc in Q2 2015 and held it in 4 quarters.
  • TFS Capital's Calithera Biosciences, Inc position peaked at $276K in Q1 2016.
  • 91 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.